Clinical trials
Completed Observational Squamous Cell Carcinoma of Head and Neck trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt-Ingram Cancer Center | 8 |
| ECOG-ACRIN Cancer Research Group | 5 |
| Bristol-Myers Squibb | 3 |
| Cairo University | 3 |
| Eastern Cooperative Oncology Group | 3 |
| Fayoum University | 3 |
| Vanderbilt University Medical Center | 3 |
| Hospices Civils de Lyon | 2 |
| Maastricht Radiation Oncology | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 91 |
| Head and Neck Neoplasms | 44 |
| Salivary Gland Neoplasms | 19 |
| Carcinoma, Squamous Cell | 10 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Esthesioneuroblastoma, Olfactory | 8 |
| Mouth Neoplasms | 6 |
| Oropharyngeal Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Lung Neoplasms | 4 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.